Interact CardioVasc Thorac Surg 2008;7:378-382. doi:10.1510/icvts.2007.169086 © 2008 European Association of Cardio-Thoracic Surgery
Work in progress report - Coronary |
Different anticoagulation strategies in off-pump coronary artery bypass operations: a European survey
Lars Englberger*,
Marianne Streich,
Hendrik Tevaearai and
Thierry P. Carrel
Department of Cardiovascular Surgery, Inselspital, University Hospital, Freiburgstrasse, 3010 Berne, Switzerland
*Corresponding author. Tel.: +41-31-632 2375; fax: +41-31-632 4443.
E-mail address: lars.englberger{at}insel.ch (L. Englberger).
In order to determine anticoagulation strategies in OPCAB a questionnaire survey among 750 European cardio-thoracic surgeons was performed. Questions addressed volume of OPCAB procedures performed, intra- and perioperative heparinization and antiplatelet therapy, as well as perioperative management. A total of 325 (43.7%) questionnaires were returned and validated. Perioperative protocols for administration of antiplatelets differed among the respondent surgeons. Perioperative prophylaxis of thrombosis (low or high molecular weight heparin) is performed by 78%. Intraoperative heparin dosage range between 70 U/kg to 500 U/kg, 60% of respondents prefer a low-dose regimen ( 150 U/kg). Correspondingly, the lowest activated clotting time (ACT) during surgery is accepted to be 200 s by 24%, 250 s by 18% and 300 s by 26% of surgeons. Protamine is used by 91% of respondents, while 52% perform a 1:1 reversal. A cell-saver and antifibrinolytics are used by 70% and 40%, respectively. Interestingly, 56% of respondents think bleeding in OPCAB patients is not reduced when compared to on-pump CABG. In addition, 34% of respondents believe there is an increased risk of early graft occlusion following OPCAB. This survey demonstrates widely different intra- and perioperative anticoagulation strategies for OPCAB procedures among European surgeons.
Key Words: OPCAB; Anticoagulation
Related Articles
-
HIT in OPCAB surgery
- Karsten Knobloch, Andreas Gohritz, Marcus Spies, and Peter M. Vogt
Interactive CardioVascular and Thoracic Surgery 2008 7: 382.
[Full Text]
[PDF]
-
Is anticoagulation management more significant for patients undergoing off-pump bypass than for those after CABG?
- Efstratios Apostolakis and Ioanna Koniari
Interactive CardioVascular and Thoracic Surgery 2008 7: 383.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
D. Paparella, F. Semeraro, G. Scrascia, A. Galeone, C. T. Ammollo, G. Kounakis, L. de Luca Tupputi Schinosa, N. Semeraro, and M. Colucci
Coagulation-Fibrinolysis Changes During Off-Pump Bypass: Effect of Two Heparin Doses.
Ann. Thorac. Surg.,
February 1, 2010;
89(2):
421 - 427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Shore-Lesserson
Invited Commentary
Ann. Thorac. Surg.,
February 1, 2010;
89(2):
427 - 428.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.P. Mehra, K.S. Shah, P.C. Jain, S.K. Bhansali, J.D. Sunawala, B.V. Gandhi, A. Oswal, and R.A. Karatela
Combined Off-pump Coronary Artery Bypass Grafting and Thyroidectomy
Ann. Thorac. Surg.,
August 1, 2009;
88(2):
661 - 663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Jervis, V. Senthilnathan, and A. B. Lerner
Management of a Patient with Lupus Anticoagulant and Antiphospholipid Syndrome for Off-Pump Coronary Artery Bypass Grafting Using the Hepcon(R) System
Anesth. Analg.,
April 1, 2009;
108(4):
1116 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Knobloch, A. Gohritz, M. Spies, and P. M. Vogt
HIT in OPCAB surgery
Interactive CardioVascular and Thoracic Surgery,
June 1, 2008;
7(3):
382 - 382.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Apostolakis and I. Koniari
Is anticoagulation management more significant for patients undergoing off-pump bypass than for those after CABG?
Interactive CardioVascular and Thoracic Surgery,
June 1, 2008;
7(3):
383 - 383.
[Full Text]
[PDF]
|
 |
|
|
|